Quality of Life and Fixed-ratio Combination of Insulin Degludec and Liraglutide (iDegLira)
Status:
Completed
Trial end date:
2021-03-25
Target enrollment:
Participant gender:
Summary
This work is aimed at improving the quality of life of older patients affected by type 2
diabetes. The investigators will try to amiliorate the complexity of hypogliceamic treatment
in a little group of older patients with type 2 diabetes reducing the number of pills and/or
insulin administration using a single daily dose of a fixed combination of insulin degludec
and liraglutide. This therapeutic semplification will be done indipendently of pre-existent
glicaemic control.